Timeline
Shield Therapeutics partner MEDLEAP confirms first patient enrollment in Japan Phase II for ACCRUFeR
More in Software & SaaS
Polar Capital Technology Trust nearly doubles NAV
"The Board maintains its high confidence in the continued success of Ben and the team," chair Catherine Cripps said.